Practical advice for eating and drinking to combat childhood obesity.

TZD drug pioglitazone becomes second-ever diabetes drug to reduce heart disease and first to reduce strokes. Who might this benefit most?

Thoughts on democratizing health care, precision medicine, and more from Stanford MedX 2015.

Incredible opportunity in San Diego will teach providers how to better motivate and support people with diabetes (Jan 22-23, Feb 26-27).

Plus, a massive $2 billion investment in new production facilities!

What I learned from doubling my carb intake: more work, more danger, but the same average blood sugar. Huh?

Marks the largest ever one-time research investment from the AHA – how Google is planning to “shake it up.”

Major organizations make it clear: diabetes education is critical!

Launch before the second half of 2016. What savings program will be offered?

Shipping now! Patients must decide between data on the phone or pump.

What does this controversial data mean for the type 2 diabetes epidemic?

New blinded sensor worn for 14 days that will give a detailed picture of your glucose levels.

My reflections on a visionary, scientist, role model, and friend.

How you can tell drug and device makers what YOU want from diabetes products.

Plus, my Resolutions for 2016!

Yesterday, Sanofi announced a partnership with Google Life Sciences to improve diabetes care through new sensors, wearable devices, and better software. The partnership...

Plus, exciting details on Google’s glucose-sensing contact lens!

Our top takeaways from the health and medicine edition of the world-famous TED conference.

The 338-patient, Dexcom-sponsored DIaMonD Study aims to find out.

A new study from Dr. Doug Melton’s team provides hope for the future of stem cell treatment in diabetes. But there’s still a long way to go.